Filing Details
- Accession Number:
- 0001179110-11-009104
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-06-02 11:35:30
- Reporting Period:
- 2011-05-31
- Filing Date:
- 2011-06-02
- Accepted Time:
- 2011-06-02 11:35:30
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1235010 | Momenta Pharmaceuticals Inc | MNTA | Biological Products, (No Disgnostic Substances) (2836) | 043561634 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1229450 | A Craig Wheeler | C/O Momenta Pharmaceuticals, Inc. 675 West Kendall Street Cambridge MA 02142 | President | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2011-05-31 | 6,700 | $20.16 | 364,766 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2011-05-31 | 5,400 | $20.16 | 171,631 | No | 4 | S | Indirect | Craig Wheeler revocable trust |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Indirect | Craig Wheeler revocable trust |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Option to purchase stock | Acquisiton | 2011-05-31 | 6,700 | $7.41 | 6,700 | $7.41 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 768,300 | 2008-05-22 | 2018-02-22 | No | 4 | M | Direct |
Footnotes
- This sale was effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on December 16, 2010.
- This transaction was executed in multiple trades at prices ranging from $20.15 to $20.19. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $20.15 to $20.20. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Billionaire Hedge Funds
